Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
anti-GSK3 β, mAb (AF12E8)
Product Details | |
---|---|
Synonyms | GSK3B; GSK-3 β; EC=2.7.11.1; EC=2.7.11.26; Glycogen Synthase Kinase-3 β; Serine/Threonine-Protein Kinase GSK3B |
Product Type | Monoclonal Antibody |
Properties | |
Clone | AF12E8 |
Isotype | Mouse IgG1 κ |
Immunogen/Antigen | Recombinant human His-GSK3B protein purified from E. coli. |
Application |
ELISA |
Crossreactivity |
Human Mouse Rat |
Purity Detail | Ammonium sulfate precipitation. |
Formulation | Liquid. HEPES with 0.15M NaCl, 0.01% BSA, 0.03% sodium azide, and 50% glycerol. |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Declaration | Manufactured by AbFrontier |
Shipping and Handling | |
Shipping | BLUE ICE |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Use/Stability | Stable for at least 1 year after receipt when stored at -20°C. |
Documents | |
MSDS | Inquire |
Product Specification Sheet | |
Datasheet |
![]() |
Glycogen synthase kinase-3β (GSK-3β) is a cytoplasmic serine/threonine protein kinase, which was initially identified as the kinase that phosphorylates glycogen synthase to inhibit glycogen synthesis. GSK3 β is a ubiquitously expressed kinase that regulates a wide variety of cellular functions including metabolism, gene expression and cytoskeletal integrity. Akt/PI3K reduces GSK-3β activity by phosphorylation of its Ser9 residue. GSK-3 β has a critical role in the regulation of the amount of cyclin D1, as this kinase is involved in both cyclin D1 mRNA transcription and ubiquitin-dependent proteolysis. Participates in the Wnt signaling pathway. Implicated in the hormonal control of several regulatory proteins including glycogen synthase, MYB and the transcription factor JUN. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates MUC1 in breast cancer cells, and decreases the interaction of MUC1 with CTNNB1/β-catenin. Phosphorylates CTNNB1/β-catenin.
1) Blankesteijn WM et al., (2008) Trends Pharmacol Sci 29(4):175-80. (General)
2) Sugden PH et al., (2008) Br J Pharmacol 153 Suppl 1:S137-53. (General)
3) Takahashi-Yanaga F and Sasaguri T, (2008) Cell Signal 20(4):581-9. (General)